Hyponatremia evaluation teach me from basics to clinical cases
Reading File
Finding Sources
Finding Sources
Searching PubMed
"hyponatremia"[MeSH Terms] AND "diagnosis"[MeSH Terms]
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
I now have comprehensive material to write a thorough, textbook-quality teaching guide. Let me compose the full response.
Hyponatremia: From Basics to Clinical Cases
A structured deep dive using Harrison's 22E, Brenner & Rector's Kidney, Tintinalli's EM, NKF Primer, and Symptom-to-Diagnosis.
Part 1 - The Physiology Foundation
Water and Sodium: Why Na+ Reflects Water Balance
Sodium is the dominant extracellular cation. But serum [Na+] tells you nothing about total body sodium - it reflects the ratio of total body sodium to total body water (TBW).
Effective plasma osmolality (tonicity):
Posm = 2 × [Na+] + glucose/18 Normal: 275-290 mOsm/kg
Two key defense mechanisms maintain osmolality:
- AVP (vasopressin/ADH) - released by posterior pituitary in response to osmoreceptors in hypothalamus. Promotes free water reabsorption via V2 receptors in the collecting duct.
- Thirst - drives oral free water intake.
When either or both of these mechanisms malfunction - and the patient continues taking in free water - hyponatremia results.
"A key concept is that the absolute plasma Na+ concentration tells one nothing about the volume status of a given patient." - Harrison's Principles, 22E
What Happens to Cells?
When plasma becomes hypotonic (low osmolality), water moves into cells by osmosis - cells swell. Brain cells swelling inside a rigid skull is what causes the neurological symptoms of hyponatremia. Conversely, if hyponatremia is chronic, brain cells adapt by exporting organic osmolytes (taurine, glutamate, myoinositol) - this is why chronic hyponatremia is better tolerated than acute.
Part 2 - Definition and Epidemiology
| Term | Definition |
|---|---|
| Hyponatremia | Serum [Na+] < 135 mEq/L |
| Symptomatic threshold | Usually ≤ 125-130 mEq/L (but varies with acuity) |
| Severe hyponatremia | < 120 mEq/L |
| Acute | Duration < 24-48 hours |
| Chronic | Duration > 48 hours |
- Occurs in up to 22% of hospitalized patients (Harrison's 22E)
- In cancer patients, prevalence: 4-47%; associated with 2-5x increased 90-day mortality (Brenner & Rector)
- Most common electrolyte disorder encountered in clinical medicine
Part 3 - Step-by-Step Diagnostic Framework
The classic approach moves through four sequential questions:
Step 1 - Is This True Hypotonic Hyponatremia?
First, measure serum osmolality and calculate effective osmolality (tonicity).
Three types of hyponatremia by osmolality:
| Type | Measured Posm | Cause | Example |
|---|---|---|---|
| Isotonic (pseudohyponatremia) | Normal (275-290) | Lab artifact | Extreme hyperlipidemia, hyperproteinemia (myeloma) |
| Hypertonic | Elevated (>290) | Osmotically active solute | Hyperglycemia, mannitol, sorbitol |
| Hypotonic (true hyponatremia) | Low (<275) | Excess free water relative to Na+ | All causes below |
Glucose correction: For every 100 mg/dL rise in glucose, serum [Na+] falls by ~1.6-2.4 mEq/L due to osmotic water efflux from cells. This is "true" hyponatremia that resolves when glucose is corrected.
In pseudohyponatremia (e.g., severe hyperlipidemia), the lab overestimates plasma water because it assumes plasma is 93% water. The measured osmolality is normal even though reported [Na+] is low. - Harrison's 22E
Step 2 - What is the Volume Status? (ECF Assessment)
This is the most important clinical step. Classify the patient into one of three categories:
| Volume Status | Clinical Signs | Pathophysiology |
|---|---|---|
| Hypovolemic | Orthostatic hypotension, tachycardia, dry mucous membranes, skin tenting, ↑BUN/Cr, ↑uric acid | Na+ and water lost; AVP rises to preserve volume |
| Euvolemic | Normal exam - no edema, no signs of depletion | Water retained without Na+ retention |
| Hypervolemic | Peripheral edema, ascites, elevated JVP, S3 gallop | Na+ and water both retained, but water excess > Na+ |
"Clinically detectable hypovolemia, determined most sensitively by careful measurement of orthostatic changes in BP and pulse, usually indicates some degree of solute depletion. Elevations of BUN and uric acid are useful laboratory correlates." - NKF Primer on Kidney Diseases, 8E
Step 3 - Urine Osmolality (Uosm)
This tells you what the kidneys are doing with water - i.e., is AVP active?
| Uosm | Interpretation |
|---|---|
| < 100 mOsm/kg | AVP is suppressed - kidney is making maximally dilute urine. Think: polydipsia (psychogenic or beer potomania), exercise-associated hyponatremia |
| 100-300 mOsm/kg | Partially diluted urine - mixed picture (partial AVP, or solute depletion limiting water excretion) |
| > 300 mOsm/kg | AVP is active - kidney is concentrating. Most clinical hyponatremia |
| > 400 mOsm/kg | AVP playing dominant role |
"Urine osmolality > 100 mOsm/L H2O with the exception of patients with psychogenic polydipsia, which drives down urine osmolality below 100." - Tintinalli's EM
Quick estimation trick: If urine osmolality not immediately available, use specific gravity (π):
Uosm ≈ (hundredths + thousandths digits of π) × 35 Example: π = 1.015 → 15 × 35 = 525 mOsm/L
Step 4 - Urine Sodium (UNa)
This tells you the kidney's sodium-handling, which helps narrow the cause within each volume category.
| Volume Status | UNa | Interpretation |
|---|---|---|
| Hypovolemic | < 20-30 mEq/L | Extra-renal Na+ loss (GI, skin) - kidneys appropriately conserving Na+ |
| Hypovolemic | > 20-30 mEq/L | Renal Na+ wasting (diuretics, adrenal insufficiency, salt-losing nephropathy, CSW) |
| Euvolemic (SIADH) | > 30 mEq/L | Inappropriately high despite low plasma [Na+] |
| Hypervolemic (CHF, cirrhosis, nephrotic) | < 10 mEq/L | Kidneys avidly retaining Na+ due to perceived underfilling |
| Hypervolemic (renal failure) | > 20 mEq/L | Kidneys cannot retain Na+ |
Caution: Thiazide diuretics can produce high UNa mimicking SIADH. Wait 1-2 weeks after stopping thiazide before diagnosing SIADH. Diuretics are the most common cause of hypovolemic hyponatremia - and thiazides cause it far more commonly than loop diuretics because they impair the diluting segment (early distal tubule) while preserving the concentrating mechanism.
The Master Diagnostic Algorithm
Fig. 7.1 - Algorithm for evaluation and treatment of hyponatremia. (NKF Primer on Kidney Diseases, 8E)
Part 4 - Causes by Volume Category
A. Hypovolemic Hyponatremia
The body loses Na+ (and water), AVP rises to defend blood pressure, and if free water is then consumed, [Na+] falls.
Extra-renal causes (UNa < 20):
- GI losses: vomiting, diarrhea, NG drainage
- Insensible losses: sweating (especially cystic fibrosis with salty sweat), burns
- Third spacing: pancreatitis, bowel obstruction
Renal causes (UNa > 20):
- Thiazide diuretics (most common - impairs NaCl cotransporter in DCT)
- Adrenal insufficiency (primary Addison's: ↓aldosterone → Na+ wasting; also hyperkalemia + hyponatremia + hypotension is a classic triad)
- Salt-losing nephropathies: reflux nephropathy, interstitial nephritis, medullary cystic disease, post-ATN recovery
- Cerebral salt wasting (CSW) - seen in intracranial pathology (SAH, TBI); must distinguish from SIADH because treatment differs (CSW requires sodium + volume replacement, not fluid restriction)
B. Euvolemic Hyponatremia
The most common category in hospitalized patients. Water is retained without a matching Na+ gain, so no obvious edema.
SIADH - Syndrome of Inappropriate Antidiuretic Hormone
Diagnostic criteria:
| Criterion | Value |
|---|---|
| Hypotonic hyponatremia | Posm < 275 mOsm/kg |
| Inappropriately elevated urine osmolality | Usually > 200 mOsm/kg |
| Elevated urine Na+ | Typically > 20 mEq/L |
| Clinical euvolemia | No signs of volume depletion or overload |
| Normal adrenal, renal, cardiac, hepatic, thyroid function | Rule out other causes |
(Tintinalli's Emergency Medicine, Table 17-6)
Causes of SIADH:
| Category | Examples |
|---|---|
| CNS disorders | Meningitis, encephalitis, brain abscess, SAH, subdural hematoma, stroke, trauma, psychosis |
| Pulmonary disorders | Pneumonia, TB, lung abscess, empyema, acute respiratory failure, positive-pressure ventilation |
| Malignancy (ectopic AVP) | Small cell lung cancer (most common - 10-15% of SCLC), pancreatic, duodenal, bladder, prostate, lymphoma |
| Medications | SSRIs/SNRIs, thiazides, carbamazepine, oxcarbazepine, cyclophosphamide, vincristine, cisplatin, NSAIDs, opioids, amiodarone, desmopressin, haloperidol, phenothiazines |
| Miscellaneous | Major surgery, pain, nausea, HIV, hypothyroidism (also separate mechanism) |
Serum uric acid in SIADH: Patients with SIAD physiology are typically hypouricemic (< 4 mg/dL) due to uricosuria from volume expansion, in contrast to hypovolemic patients who are hyperuricemic.
U/P electrolyte ratio: Calculate (urine [Na+] + urine [K+]) / plasma [Na+]:
- Ratio > 1: Aggressively restrict fluids to < 500 mL/day
- Ratio ~1: Restrict to 500-700 mL/day
- Ratio < 1: Restrict to < 1 L/day This predicts responsiveness to fluid restriction.
Other Euvolemic Causes:
- Hypothyroidism: Reduced cardiac output → reduced GFR + non-osmotic AVP release. TSH is essential in the workup.
- Secondary adrenal insufficiency (pituitary/hypothalamic): Unlike primary Addison's (which is hypovolemic with hyperkalemia), secondary AI is euvolemic and normokalemic - aldosterone is intact, only cortisol is deficient. Cosyntropin stimulation test differentiates.
- Beer potomania / low solute intake: Extremely low solute intake limits the kidneys' ability to excrete free water regardless of AVP status. Uosm is typically very low (100-200s), UNa < 20. High risk of ODS upon treatment due to associated hypokalemia + malnutrition.
- Psychogenic polydipsia: Massive water intake overwhelms renal excretion. Uosm < 100 (maximally dilute - AVP is suppressed). Common in schizophrenia.
- Exercise-associated hyponatremia (EAH): Acute, from excessive hypotonic fluid intake during endurance events, combined in ~44% of cases with SIADH. Weight gain during race is the key clue. Uosm < 100 in pure water intoxication. Dangerous because acute onset causes severe symptoms.
C. Hypervolemic Hyponatremia
Both Na+ and water are retained, but water exceeds Na+. There is "effective arterial underfilling" - the body perceives low perfusion despite expanded ECF, leading to neurohumoral activation and AVP release.
| Cause | UNa | Key Features |
|---|---|---|
| Congestive heart failure | < 10 mEq/L | ↑JVP, S3, dyspnea, BNP elevated |
| Cirrhosis | < 10 mEq/L | Ascites, spider angiomata, asterixis, ↑bilirubin |
| Nephrotic syndrome | < 10 mEq/L | Massive proteinuria, edema, hypoalbuminemia |
| Advanced renal failure | > 20 mEq/L | ↑Cr, ↑K+, uremic features |
Part 5 - Symptoms and Severity
Symptoms are primarily neurological due to cerebral edema:
| Severity | Symptoms |
|---|---|
| Mild (130-135) | Often asymptomatic; nausea, malaise |
| Moderate (125-130) | Headache, lethargy, confusion, muscle cramps |
| Severe (<125, especially acute) | Seizures, obtundation, respiratory arrest, brain herniation, coma, death |
Acute vs. chronic matters clinically:
- Acute hyponatremia (< 48 h) - brain hasn't adapted, symptoms occur at higher [Na+] levels, risk of herniation
- Chronic hyponatremia (> 48 h) - brain has adapted by losing organic osmolytes, symptoms may be minimal even at [Na+] 115-120
Part 6 - Treatment
Three Governing Principles (Harrison's 22E)
- Symptom severity determines urgency
- Overcorrection risk - ODS in chronic hyponatremia
- Monitor frequently - response to treatment is unpredictable
Treatment by Category
Symptomatic / Acute / Severe
Hypertonic 3% NaCl is the treatment for acute life-threatening hyponatremia (seizures, coma):
| Step | Action |
|---|---|
| 1 | Give 100-150 mL of 3% NaCl IV over 15-20 minutes |
| 2 | Check serum [Na+] after each infusion |
| 3 | Stop when symptoms improve OR [Na+] rises 4-6 mEq/L |
| 4 | May repeat up to 3 doses (total 450 mL) |
| 5 | Limit total correction to ≤ 8-12 mEq/L in first 24 h, ≤ 18 mEq/L in 48 h |
(Tintinalli's EM, Table 17-7)
Chronic Mild-Moderate Hyponatremia - By Cause
| Cause | Treatment |
|---|---|
| Hypovolemic | Isotonic normal saline (0.9% NaCl) - repletes volume → AVP suppresses → water diuresis corrects [Na+]. Correct K+ as needed. |
| SIADH / euvolemic | Fluid restriction (first-line); oral Na+ supplementation; urea; demeclocycline; vaptans (tolvaptan, conivaptan) |
| CHF / hypervolemic | Treat underlying cause (ACE-I, diuretics, optimize cardiac output); fluid restriction; vaptans for refractory cases |
| Hypothyroidism | Thyroid hormone replacement |
| Adrenal insufficiency | Corticosteroid replacement |
| Beer potomania / low solute | IV saline + resume normal diet; high-risk for ODS |
| EAH (acute) | Hypertonic saline urgently if symptomatic; fluid restriction; stop hypotonic fluid intake |
Fluid restriction guidance (SIADH): Use the urine-to-plasma electrolyte ratio to individualize:
- U/P ratio > 1 → restrict to < 500 mL/day
- U/P ratio ~1 → 500-700 mL/day
- U/P ratio < 1 → < 1 L/day
Vaptans (AVP V2 receptor antagonists - tolvaptan, conivaptan): Cause selective free water excretion (aquaresis). Indicated in SIADH and hypervolemic hyponatremia refractory to other measures. A 2025 meta-analysis (PMID 40288608) confirmed low-dose tolvaptan is effective and safe for SIADH. Contraindicated in hypovolemic hyponatremia (will worsen volume depletion). Must start in hospital with close monitoring due to overcorrection risk.
Urea (oral): Increases solute load → increases free water excretion. A 2025 systematic review (PMID 39362395) confirmed efficacy and safety for SIADH hyponatremia.
Part 7 - Osmotic Demyelination Syndrome (ODS)
The most feared complication of hyponatremia treatment.
Mechanism
When chronic hyponatremia is corrected too rapidly, water exits brain cells into a now hypertonic ECF. Brain cells that had lost organic osmolytes during adaptation are left with insufficient osmolytes to maintain volume - leading to intracellular dehydration and myelin damage. The pons is most vulnerable - hence the older term central pontine myelinolysis (CPM).
Risk Factors for ODS
- Serum [Na+] < 120 mEq/L
- Duration > 48 hours (chronic)
- Hypokalemia
- Alcoholism, cirrhosis
- Malnutrition
- Beer potomania (extremely high risk)
- Use of vaptans
Correction Limits
| Time Period | Max Safe Correction |
|---|---|
| First 24 hours | ≤ 8-10 mEq/L (some guidelines allow up to 12 for acute) |
| First 48 hours | ≤ 18 mEq/L |
Clinical Presentation of ODS
Symptoms appear 2-6 days AFTER rapid correction (not immediately):
- Dysarthria, dysphagia
- Behavioral changes, lethargy
- Paraparesis or quadriparesis
- Locked-in syndrome (in severe cases)
- Seizures, coma
If Overcorrection Occurs
- Administer 5% dextrose in water at 3 mL/kg/h
- Add desmopressin (DDAVP) to stop further free water excretion
- Loop diuretics
- Goal: bring [Na+] back down toward the safe correction target
Part 8 - Clinical Cases
Case 1 - The Dehydrated Vomiter
67-year-old woman presents with 3 days of vomiting and decreased PO intake. BP 95/60 mmHg lying, 78/50 mmHg standing (orthostatic drop). HR 112. Dry mucous membranes. Skin tenting. No edema.
Labs: [Na+] 124, K+ 3.1, Cl- 88, BUN 42, Cr 1.6, glucose 95, serum Posm 258. Urine [Na+] 8, Uosm 680.
Analysis:
- Step 1: Posm 258 - true hypotonic hyponatremia ✓
- Step 2: Clearly hypovolemic (orthostatics, tachycardia, dry MM, ↑BUN/Cr, ↑uric acid presumed)
- Step 3: Uosm 680 - AVP is very active (kidney concentrating urine to preserve volume)
- Step 4: UNa 8 - extra-renal Na+ loss (kidneys are avid for Na+ - GI losses)
Diagnosis: Hypovolemic hyponatremia from GI losses
Treatment: Isotonic normal saline (0.9% NaCl). As volume is restored → baroreceptors detect volume repletion → AVP suppresses → brisk water diuresis → [Na+] corrects. Also correct K+ (hypokalemia can drive further [Na+] falls and is an ODS risk factor). Monitor [Na+] every 4-6 hours to avoid overcorrection. Limit correction to < 10 mEq/L in first 24 h.
Case 2 - The SIADH Patient
52-year-old man with small cell lung cancer presents with fatigue, confusion, and headache for 1 week. No edema, no orthostasis, no signs of volume depletion.
Labs: [Na+] 118, K+ 3.9, BUN 12, Cr 0.8, glucose 90, serum Posm 242. Urine [Na+] 65, Uosm 520. Serum uric acid 2.8 mg/dL.
Analysis:
- Step 1: Posm 242 - true hypotonic hyponatremia ✓
- Step 2: Euvolemic - no edema, no depletion
- Step 3: Uosm 520 - AVP is active despite hyponatremia (inappropriate)
- Step 4: UNa 65 - very high (kidney not retaining Na+)
- Serum uric acid < 4 → SIADH physiology
- Clinical context: SCLC producing ectopic AVP
Diagnosis: SIADH from paraneoplastic (small cell lung cancer)
U/P electrolyte ratio: (65 + 18) / 118 ≈ 0.70 → restrict to < 1 L/day
Treatment: Fluid restriction < 1 L/day. Consider oral sodium tablets + urea to increase solute load. If refractory, tolvaptan (in-hospital initiation). Treat underlying SCLC - AVP levels track with tumor response.
Important: Cancer-associated hyponatremia is associated with 2-5x higher 90-day mortality. Serial [Na+] tracks disease course.
Case 3 - The Marathon Runner
29-year-old woman collapses 30 minutes after completing a marathon. She is confused and seizing. Bystanders report she drank water continuously during the race. Weight gain noted during race.
Labs: [Na+] 112, Posm 228. Uosm 68. UNa 12.
Analysis:
- Uosm < 100 → AVP is SUPPRESSED → maximally dilute urine
- This is acute water intoxication, not chronic hyponatremia
- UNa 12 reflects some sodium conservation but is less useful here
- The low Uosm with acute onset during endurance event = Exercise-Associated Hyponatremia (EAH)
Treatment (Emergency): This is acute, life-threatening, symptomatic hyponatremia. Despite the "slow" risk of ODS from rapid correction, acute hyponatremia presenting with seizures/coma requires immediate hypertonic saline:
- 150 mL of 3% NaCl IV over 20 minutes
- Recheck [Na+], may repeat up to 3 times
- Stop when seizures resolve or [Na+] rises 4-6 mEq/L
- Since this is acute (< 24 hours), the risk of ODS is low - the brain has not had time to adapt by losing osmolytes
Case 4 - Thiazide Mimic of SIADH
72-year-old woman started on HCTZ 3 weeks ago for hypertension. Presents with weakness, mild confusion. No edema, no orthostasis.
Labs: [Na+] 122, Posm 256, Uosm 380, UNa 45, K+ 2.8.
Analysis:
- Looks exactly like SIADH - euvolemic, high UNa, high Uosm
- But: started thiazide 3 weeks ago, hypokalemia (K+ 2.8)
- Thiazide mechanism: blocks NaCl cotransporter in DCT (diluting segment) → impairs water excretion + volume depletion → AVP rises + polydipsia
Pitfall: Do NOT diagnose SIADH until 1-2 weeks after stopping the thiazide. The low K+ is an important clue - few causes of hyponatremia also produce significant hypokalemia.
Treatment: Stop thiazide. Correct K+ (KCl replacement will itself raise [Na+]). Normal saline if symptomatic. Monitor closely. Consider switching to loop diuretic if BP control still needed.
Case 5 - Adrenal Crisis
38-year-old man with HIV, fatigue, nausea, hyperpigmentation, weight loss. BP 88/55, HR 105.
Labs: [Na+] 126, K+ 5.9, glucose 58, BUN 28, Cr 1.2, Posm 268. Uosm 520, UNa 68.
Analysis:
- Hypovolemic + hyperkalemia + hyponatremia + hypotension → classic triad
- Hyperpigmentation in HIV patient → think primary adrenal insufficiency (Addison's disease - HIV can cause adrenal infiltration by CMV, MAI, or direct HIV)
- High UNa despite hypovolemia → kidneys cannot retain Na+ (no aldosterone)
Diagnosis: Primary adrenal insufficiency (Addison's disease)
Treatment: IV hydrocortisone 100 mg immediately + isotonic saline. Cosyntropin stimulation test (if time permits before starting steroids, draw cortisol level first). Do not delay treatment for test results in a sick patient.
Part 9 - High-Yield Summary Table
| Condition | Volume | Uosm | UNa | Key Clue | Treatment |
|---|---|---|---|---|---|
| GI losses | ↓ | High | < 20 | Orthostasis, vomiting/diarrhea | 0.9% NS |
| Thiazide | ↓ or euvolemic | High | > 20 | Hypokalemia, recent thiazide | Stop drug, correct K+ |
| Adrenal insufficiency (primary) | ↓ | High | >> 20 | Hyperkalemia, hyperpigmentation | Hydrocortisone + NS |
| CSW | ↓ | High | > 20 | CNS pathology (SAH, TBI) | Na+ + volume |
| SIADH | Euvolemic | > 200 | > 30 | Exclusion diagnosis | Fluid restriction ± urea ± vaptan |
| Hypothyroidism | Euvolemic | Variable | Variable | Fatigue, myxedema, ↑TSH | T4 replacement |
| Secondary AI | Euvolemic | High | > 20 | Normokalemic, pituitary disease | Cortisol |
| Beer potomania | Euvolemic | < 100-200 | < 20 | Alcoholism, low solute diet | NS + diet; high ODS risk |
| Psychogenic polydipsia | Euvolemic | < 100 | Low | Psychiatric hx, schizophrenia | Fluid restriction, treat psych |
| EAH | Euvolemic | < 100 | Low | Post-endurance event, weight gain | Hypertonic saline if severe |
| CHF | ↑ | High | < 10 | Edema, ↑JVP, ↑BNP | Treat CHF, fluid restrict, vaptan |
| Cirrhosis | ↑ | High | < 10 | Ascites, spider angiomata | Treat liver disease, fluid restrict |
| Renal failure | ↑ | Variable | > 20 | ↑Cr, ↑K+ | Dialysis |
Part 10 - Recent Evidence Updates (2024-2026)
- Tolvaptan (PMID 40288608, 2025): Systematic review/meta-analysis confirmed low-dose tolvaptan is effective and safe for SIADH-associated hyponatremia, with comparable efficacy to standard doses but fewer adverse effects.
- Urea (PMID 39362395, 2025): Meta-analysis of urea vs. other treatments for SIADH hyponatremia confirmed urea is effective, safe, inexpensive, and under-utilized. Particularly useful when fluid restriction is poorly tolerated.
- Point-of-care ultrasound (PMID 41528666, 2026): Systematic review supports POCUS as a complementary tool in hyponatremia evaluation for assessing ECF volume status (IVC collapsibility, lung B-lines for CHF, ascites for cirrhosis) - particularly valuable when clinical volume assessment is uncertain.
Quick Reference: The 4-Question Framework
1. Is Posm low? (True hypotonic hyponatremia?)
↓
2. What is the ECF volume? (Hypo / Eu / Hypervolemic?)
↓
3. What is Uosm? (Is AVP active?)
↓
4. What is UNa? (Renal vs. extra-renal? Appropriate vs. inappropriate?)
Once you have these four answers + the clinical context, the diagnosis is almost always apparent.
Sources: Harrison's Principles of Internal Medicine 22E (2025); NKF Primer on Kidney Diseases 8E; Tintinalli's Emergency Medicine; Symptom to Diagnosis 4E; Brenner & Rector's The Kidney; PubMed: PMID 40288608, 39362395, 41528666
This is a shared conversation. Sign in to Orris to start your own chat.